ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

Stryker CEO Kevin Lobo announced a roughly $400 million preferred-equity investment in London-based CMR Surgical, the maker of the Versius soft-tissue robot. This deal makes Stryker the exclusive U.S. sales agent for Versius and grants an option to buy all of CMR later.
Tap to vote and see what everyone thinks.
Summary by ByteBrief

Paris-based Genesis AI, which is building a general-purpose robot with greater dexterity for warehouses and homes, raised a $500M Series A at a $3.5B valuation (Steven Rosenbush/Wall Street Journal)

Genesis AI Raises $500 Million Series A

US Robot Production Hits 400k by 2030